bucillamine antirheumatic agent developed tiopronin activity mediated two thiol groups molecule contains research done usa showed positive transplant preservation bucillamine currently investigated drug repurposing bucillamine wellknown safety profile prescribed treatment rheumatoid arthritis japan south korea years cysteine derivative thiol groups potent acetylcysteine nac thiol donor vivo giving vastly superior function restoring glutathione therefore greater potential prevent acute lung injury influenza bucillamine also shown prevent oxidative reperfusion injury heart liver bucillamine proven safety proven mechanism action similar nac much higher potency mitigating previous obstacles using thiols therapeutically hypothesized similar processes related reactive oxygen species ros involved acute lung injury infection possibly justifying investigation bucillamine intervention july us food drug administration fda approved revive therapeutics ltd proceed randomized doubleblind placebocontrolled confirmatory phase clinical trial protocol evaluate safety efficacy bucillamine patients mildmoderate drug article relating musculoskeletal system stub help wikipedia expanding httpsenwikipediaorgwikibucillamine